Related Experiment Videos
IgE lambda monoclonal gammopathy and amyloidosis
J M Jako1, T Gesztesi, I Kaszas
1First Department of Internal Medicine, Imre Haymal School of Health Sciences, Budapest, Hungary.
International Archives of Allergy and Immunology
|April 1, 1997
Summary
This case report details the first IgE myeloma diagnosis in Hungary, highlighting its rare and aggressive nature. Early detection of monoclonal chains in urine years before diagnosis is crucial for understanding this unusual myeloma variant.
Area of Science:
- Hematology
- Oncology
- Immunology
Background:
- IgE myeloma is a rare plasma cell disorder, accounting for 0.01% of all plasmocytomas.
- It is characterized by a more aggressive clinical course compared to other monoclonal gammopathies.
- IgE myeloma often presents with unique complications not typically seen in other myeloma types.
Observation:
- This case report describes the first documented instance of IgE myeloma in Hungary.
- The patient presented with an unusual clinical course and diagnostic journey.
- A significant observation was the detection of a monoclonal chain in the patient's urine years before the myeloma diagnosis.
Findings:
- IgE myeloma exhibits a variable presentation and a generally more malignant progression.
- The disease is associated with rare complications, underscoring its distinct pathology.
- This case highlights the potential for long-term presence of aberrant immunoglobulin E (IgE) protein.
Implications:
- This case contributes to the limited understanding of IgE myeloma's clinical behavior.
- Early identification of monoclonal proteins, even years prior, may be critical for timely diagnosis.
- Further research into IgE myeloma is warranted due to its rarity and aggressive nature.